IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase I drugs for Spinal Cord Disorders have an 86% phase transition ...
Pain relief is the most important goal of treating osteoarthritis (OA). When joints don’t hurt, it’s easier to move, manage everyday activities, and exercise. There are many options for treating OA ...
Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder caused by mutations in SMN1, with disease severity influenced by the number of SMN2 copies. Although SMA is one of the most common ...
Spinal tumors in children are very rare. They can be malignant (cancerous) or benign (non cancerous). As spine tumors grow, they can put pressure on the spinal cord, resulting in neurologic symptoms.
The study, which followed four patients with chronic spinal cord injuries for five years, found that two patients showed durable evidence of neurological improvement after treatment with neural ...
Facet arthropathy, also known as facet osteoarthritis, is a type of wear-and-tear arthritis affecting the spine. It affects the bony protrusions, called facet joints, that connect the bones of the ...